Production (Stage)
D
LAVA Therapeutics N.V. LVTX
$1.32 $0.021.54% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

03/31/2025 12/31/2024 09/30/2024 06/30/2024 03/31/2024
Revenue -60.20% 77.01% -18.89% -69.51% -36.01%
Total Other Revenue -- -- -- -- --
Total Revenue -60.20% 77.01% -18.89% -69.51% -36.01%
Cost of Revenue -30.08% -31.88% 882.96% 886.23% 3,675.38%
Gross Profit 13.35% 57.06% -542.88% -220.91% -220.96%
SG&A Expenses 0.81% -3.20% -8.25% -9.52% -1.20%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -18.02% -24.53% -38.97% -45.49% -22.41%
Operating Income 1.45% 40.37% 42.66% 30.96% 15.33%
Income Before Tax 3.64% 41.03% 45.50% 40.77% 20.91%
Income Tax Expenses 208.24% 145.14% 1.40% -13.83% -2.30%
Earnings from Continuing Operations 1.74% 39.89% 45.24% 40.58% 20.78%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 1.74% 39.89% 45.24% 40.58% 20.78%
EBIT 1.45% 40.37% 42.66% 30.96% 15.33%
EBITDA 0.84% 40.60% 43.07% 31.46% 15.81%
EPS Basic 3.36% 40.96% 46.32% 41.28% 21.44%
Normalized Basic EPS 0.73% 51.28% 46.58% 41.45% 21.57%
EPS Diluted 3.36% 40.96% 46.32% 41.28% 21.44%
Normalized Diluted EPS 0.73% 51.28% 46.58% 41.49% 21.62%
Average Basic Shares Outstanding 1.21% 1.60% 1.97% 1.87% 1.86%
Average Diluted Shares Outstanding 1.21% 1.60% 1.97% 1.29% 1.28%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --